All answers must be correct and detailed.

Managerial accounting case study, The case describes AXA's corporate responsibility (CR) function. The company, a global leader in insurance and asset management, had distinguished itself in CR since formally establishing a CR unit in 2008. As the case opens, AXA's CR unit is being moved from the marketing function to the strategy group occasioning a thorough review as to how CR should fit into AXA's operations and strategy. Students are asked to identify CR issues of particular concern to the company, examine how addressing these issues would add value to the company, and then create metrics that would capture a business unit's success or failure in addressing the concerns.

Question 1 I would like to know the exact mechanism of entry of potassium into cells under the influence of insulin. Question 2 I am seeing an increasing number of diabetic patients in primary care who have elevated fasting blood glucose readings but postprandial measurements that are normal or only slightly high. Does this indicate insulin resistance in these patients? What is the reason for this trend? Question 3 What are the latest diagnostic criteria for the diagnosis of diabetes mellitus? Question 4 What test is recommended for diabetes and can the same be used to diagnose diabetes in a child? Question 5 What is the value of glycosylated haemoglobin (HbA1C) in diabetes mellitus? Question 6 I read in a book that in diabetics the random blood sugar is more important than the fasting; on a medical website I noted that, for a patient with type 2 diabetes, the fasting blood sugar level is more important. What do you say? Is it acceptable to let the fasting blood sugar remain at approximately 1.5 mmol/L above the upper limit in a patient of 60 years with type 2 and presently on oral therapy? 19 Diabetes mellitus and other disorders of metabolism 198 Diabetes mellitus and other disorders of metabolism 19 199 Question 7 In type 2 diabetes, which blood sugar - fasting or random - is more revealing prognostically? Question 8 Why are the fasting and 2-hour blood glucose levels needed in a diabetic patient being treated with oral antidiabetic drugs? Question 9 Is it sufficient to use a fasting blood sugar and glycosylated haemoglobin (HbA1C) level as a guide to modify the insulin or oral antidiabetic dose without considering the 1 and 2 hour postprandial values? Question 10 What is the value of the 2-hour postprandial blood sugar level above which the dose of an oral antidiabetic should be increased if this value is exceeded several times despite dietary modification?